Head of Droplet-Based Microfluidics Applications
US$160,000 – US$180,000 / yr base salary
Posted 28 Sep 2026
Advertised as “Head of Droplet-based Microfluidics Applications - Associate Director”
BranchFactor Summary
The original posting with the fluff stripped out
- Expected experience
- 3+ yrs
- Management level
- People management
- Employment
- On-Site
| Base salary | US$160,000 – US$180,000 / yr |
|---|---|
| Cash bonus | US$16,000 – US$18,000 |
| Total comp | US$176,000 – US$198,000 |
Field of studyEngineering, Physical Science
Study levelDoctorate
Field of studyApplied Physics, Bioengineering, Biotechnology, Chemical Engineering, Electrical Engineering, Mechanical Engineering, Physics
Study levelDoctorate
About Us:
Shennon Biotechnologies is developing precision immunotherapies for solid tumors through an integrated technology platform spanning target discovery, ultra-high-throughput microfluidics-driven functional screening, computational binder design and predictive safety assessment. In particular, where conventional discovery tests binders sequentially over months, our functional screening platform TCELERATOR profiles more than 10 million single-cell interactions at once, identifying functional leads in a single experiment. The unified engine is supported by proprietary human tumor datasets and an expanding network of academic and clinical collaborators. We are developing both antibody-based and TCR-based T-cell engagers designed to address surface and intracellular cancer targets. Our initial oncology pipeline includes programs in small cell lung cancer, ovarian cancer and hepatocellular carcinoma. We are based in the dogpatch neighborhood of San Francisco with 6000 sqft of lab space. For more information, visit www.shennonbio.com.
The Role:
Reporting directly to the Chief Technology Officer, the Associate Director of Droplet-based Microfluidics Applications should be an experienced leader with hands-on expertise in droplet-based microfluidic applications (such as droplet-based sequencing and/or droplet-based screening), who can think across biology and engineering to drive solutions in functional biology, and find new preclinical or clinical applications. This person is expected to execute and expand the platform strategies towards ShennonBio’s vision. This person will lead the development of applications based on our droplet-based microfluidics platform, and the further strengthening of this platform. This person will play a critical role in ensuring the company’s competitive differentiation. We expect this person to drive the engineering platform, manage the engineering staff, and actively develop solutions to better understand functional biology.
ShennonBio envisions this role being filled by a mature leader who has an adaptive and self-starter attitude, and a strong background in both engineering and biology. This leader shall also be fluent with data structures that go into training AI models. The ideal candidate should have hands-on experience and in-depth understanding of droplet-based applications to know what is possible, what are the current boundaries and how to push them eventually.
You will work with an interdisciplinary team, and have direct access to a member of our Scientific Advisory Board who is one of the founders of droplet microfluidics (Scientific Advisory Board available here).
Responsibilities:
- Lead the further development of the droplet-based microfluidics platform and more importantly its applications, with boots on the ground, working alongside the junior engineers